首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis
【24h】

Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis

机译:使用生物信息分析鉴定与喉鳞癌的发病机制和预后结果相关的核心生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Despite advances in the treatment of laryngeal squamous-cell carcinoma (LSCC), the survival rate of LSCC remains poor. Thereby, it is urgent to identify novel diagnostic and prognostic biomarkers for LSCC. The study aimed to identify potential core genes associated with the pathogenesis and prognosis of LSCC. Methods Differentially expressed genes between LSCC and normal laryngeal tissue samples were screened by an integrated analysis of data from GEO and TCGA databases. Core genes related to the pathogenesis and prognosis of LSCC were identified by employing protein-protein interaction network and Cox proportional hazards model analyses. Results Ten hub genes (AURKA, AURKB, CDC45, KIF2C, NDC80, EXO1, TYMS, RAD51AP1, ITGA3, and UBE2T) that might be highly related to the pathogenesis of LSCC were identified. An eight-gene prognostic signature consisted of ZG16B, STATH, RTN4R, MSRA, CBX8, SLC5A1, EFNB1 and CNTFR was constructed with a good performance in predicting overall survivals. Conclusion Our findings might shed some new light on the pathogenesis of LSCC and help identify new therapeutic targets of LSCC.
机译:目的尽管治疗喉鳞状细胞癌(LSCC),但LSCC的存活率仍然差。因此,迫切需要鉴定LSCC的新型诊断和预后生物标志物。该研究旨在识别与LSCC发病机制和预后相关的潜在核心基因。方法通过从地理和TCGA数据库的数据的综合分析筛选LSCC和正常喉部组织样本之间的差异表达基因。通过使用蛋白质 - 蛋白质相互作用网络和Cox比例危害模型分析来确定与LSCC的发病机制和预后相关的核心基因。结果十个集线基因(Aurka,Aurkb,CDC45,KIF2C,NDC80,EXO1,TYM,RAD51AP1,ITGA3和UBE2T),其与LSCC的发病机制有关。构建了由ZG16B,静态,RTN4R,MSRA,CBX8,SLC5A1,EFNB1和CNTFR组成的八基因预后签名,具有良好的性能,以预测整体幸存。结论我们的研究结果可能会对LSCC发病机制产生一些新的光线,并有助于确定LSCC的新治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号